CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
155 hedge funds and large institutions have $292M invested in Clovis Oncology, Inc. in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 37 reducing their positions, and 26 closing their positions.
Holders
155
Holders Change
-3
Holders Change %
-1.9%
% of All Funds
2.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
56
Reduced
37
Closed
26
Calls
$9.32M
Puts
$10.1M
Net Calls
-$772K
Net Calls Change
+$3.45M
Top Buyers
1 |
1
State Street
Boston,
Massachusetts
|
$65.4M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$54.8M |
3 |
3
BlackRock
New York
|
$42.3M |
4 |
4
UBS Group
Zurich,
Switzerland
|
$4.23M |
5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$5.58M |